Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer

Condition:   Endometrial Cancer Intervention:   Drug: anlotinib and anti PD-1 antibody Sponsor:   Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials